Does amiodarone decrease heart rate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone's Effect on Heart Rate

Yes, amiodarone decreases heart rate through multiple mechanisms including calcium channel and beta-receptor blockade, which slow heart rate and atrioventricular nodal conduction. 1

Mechanisms of Heart Rate Reduction

Amiodarone reduces heart rate through several electrophysiologic effects:

  • Calcium channel blockade: Inhibits calcium channels in the sinoatrial and atrioventricular nodes
  • Beta-adrenergic receptor blockade: Produces sympatholytic effects
  • Prolongation of refractoriness: Via potassium and sodium channel blockade
  • Slowing of intracardiac conduction: Via sodium channel blockade 1, 2

These combined effects make amiodarone particularly effective at controlling heart rate in both atrial and ventricular arrhythmias.

Clinical Evidence of Heart Rate Reduction

Amiodarone has demonstrated significant heart rate reduction in multiple clinical scenarios:

  • In critically ill patients with atrial tachyarrhythmias resistant to conventional treatments, intravenous amiodarone (242 ± 137 mg over 1 hour) decreased heart rate by 37 ± 8 beats/min 3
  • Amiodarone effectively controls heart rate in patients with atrial fibrillation when conventional measures are ineffective 1
  • In patients with paroxysmal atrial tachyarrhythmias, appropriate dosing of amiodarone can achieve and maintain heart rates between 80-115 bpm within the first day of treatment 4

Factors Affecting Heart Rate Control

The efficacy of amiodarone in controlling heart rate can be influenced by several factors:

  • Type of arrhythmia: Patients with persistent atrial tachyarrhythmias may require twice the dose compared to those with paroxysmal arrhythmias 4
  • Concomitant treatments:
    • Intravenous magnesium and fluid loading enhance heart rate reduction
    • Dobutamine may diminish the heart rate-lowering effect 4
  • Previous amiodarone treatment: Patients previously treated with amiodarone may require different dosing strategies 4

Clinical Applications

Amiodarone is particularly valuable for heart rate control in specific clinical scenarios:

  • Atrial fibrillation: When conventional measures (beta-blockers, calcium channel blockers, digoxin) are ineffective 1
  • Heart failure patients: Amiodarone can be used safely for rate control without significant negative inotropic effects that might worsen heart failure 1
  • Wolff-Parkinson-White syndrome: Unlike beta-blockers, digitalis, and calcium channel antagonists (which are contraindicated), amiodarone can be used safely in patients with ventricular pre-excitation 5

Dosing Considerations for Heart Rate Control

For optimal heart rate control:

  • Loading dose: 600-800 mg daily in divided doses until a total of 10g has been administered 5
  • Maintenance dose: 200-400 mg daily, adjusted based on clinical response 5
  • Intravenous administration: For acute heart rate control in critically ill patients, typically 150-300 mg over 10 minutes, followed by infusion 3

Monitoring and Precautions

When using amiodarone for heart rate control:

  • ECG monitoring: Watch for QT interval prolongation, bradycardia
  • Electrolyte balance: Maintain potassium and magnesium levels (>4.0 mEq/L)
  • Drug interactions: Adjust doses of concomitant medications, especially warfarin and digoxin 5
  • Contraindications: Severe sinus node dysfunction, AV block without pacemaker, cardiogenic shock, severe bradycardia without pacemaker 5

Potential Adverse Effects Related to Heart Rate

  • Bradycardia: Can occur in approximately 4.9% of patients receiving intravenous amiodarone 6
  • Heart block: May worsen existing conduction disorders
  • Proarrhythmia: Primarily torsade de pointes associated with QTc prolongation 6

Amiodarone's heart rate-lowering effects make it valuable in many clinical scenarios, but its use requires careful monitoring due to its complex pharmacology and potential for adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.

Journal of the American College of Cardiology, 1984

Guideline

Amiodarone Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.